Dr. Maria Trent, a Professor of Pediatrics and Public Health at Johns Hopkins Medicine, is spearheading efforts to raise awareness and learn more about Mycoplasma genitalium, a sexually transmitted disease...
Updated Draft BASHH guidelines on the management of gonorrhoea indicate ciprofloxacin as preferential treatment over ceftriaxone if susceptibility is known. ResistancePlus® GC will be the first commercially available molecular test to...
SpeeDx announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus® MG. "This test is an exciting new development that will increase the precision of patient care...
The British Association of Sexual Health and HIV (BASHH) draft guidelines for Mycoplasma genitalium (Mgen) were posted for consultation and recommend Resistance Guided Therapy as best practice when treating an...
In her interview with Dr Norman Swan on ABC Radio National Health Report, Dr. Bradshaw discusses a new successful treatment pathway for Mycoplasma genitalium in a population exhibiting rising rates...
SpeeDx ResistancePlus® MG test supports new STI management guidelines SpeeDx Pty. Ltd. today announced clinical data contained in a new study published in the June 2018 issue of Clinical Infectious Diseases...
SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale in the United States through the company’s recently incorporated US...
SpeeDx Multiplexed VZV, Herpes, Syphilis Assay is now fully registered as an IVD in the Australian market. The single-well test is designed to detect and differentiate the main causes of genital...
You may have never heard of it, but Mycoplasma genitalium - MG for short - is one of the most common sexually transmitted infections in Australia. Like chlamydia, MG can...
…but many people have never heard of it. The bacterium can cause painful urination, itching and bleeding in the rectum, and in women has been linked to pelvic inflammatory disease,...